30 min listen
The hidden risks of weight loss drugs
The hidden risks of weight loss drugs
ratings:
Length:
20 minutes
Released:
Mar 11, 2024
Format:
Podcast episode
Description
GLP-1 agonists, medications originally formulated to treat diabetes, have gained traction as prescription drugs for weight loss. On this episode, medical researcher and patient advocate Ragen Chastain discusses what healthcare providers should be sharing with their patients about the risks and efficacy of Wegovy and Zepbound.
Released:
Mar 11, 2024
Format:
Podcast episode
Titles in the series (100)
Rep. Suzan Delbene's value-based payment legislation and Humana's population health milestone in Medicare Advantage markets: Rich Daly interviews Rep. Suzan Delbene about the Value in Health Care Act, proposed legislation that would make a series of hospital-supported changes to value-based programs operated by Medicare. Andrew Renda of Humana talks about how the company impro... by HFMA’s Voices in Healthcare Finance